机构:[1]Kunming Med Univ, Affiliated Hosp 1, Dept Pulm & Crit Care Med, Kunming, Peoples R China昆明医科大学附属第一医院[2]Kunming Med Univ, Anesthesiol, Kunming, Peoples R China[3]295 Xichang Rd, Kunming, Peoples R China
High-mobility group box 1 (HMGB1) is a highly conserved nonhistone nuclear protein found in the calf thymus and participates in a variety of intracellular processes such as DNA transcription, replication and repair. In the cytoplasm, HMGB1 promotes mitochondrial autophagy and is involved in in cellular stress response. Once released into the extracellular, HMGB1 becomes an inflammatory factor that triggers inflammatory responses and a variety of immune responses. In addition, HMGB1 binding with the corresponding receptor can activate the downstream substrate to carry out several biological effects. Meanwhile, HMGB1 is involved in various signaling pathways, such as the HMGB1/RAGE pathway, HMGB1/NF-kappa B pathway, and HMGB1/JAK/STAT pathway, which ultimately promote inflammation. Moreover, HMGB1 may be involved in the pathogenesis of asthma by regulating downstream signaling pathways through corresponding receptors and mediates a number of signaling pathways in asthma, such as HMGB1/TLR4/NF-kappa B, HMGB1/RAGE, HMGB1/TGF-beta, and so forth. Accordingly, HMGB1 emerges as a therapeutic target for asthma. High-mobility group box 1 (HMGB1) is a highly conserved non-histone nuclear protein found in the calf thymus and participates in a variety of intracellular processes such as DNA transcription, replication, and repair. HMGB1 emerges as a therapeutic target for asthma.image
基金:
National Natural Science Foundation of China; Student Innovation Fund Project of Kunming Medical University; First Affiliated Hospital of Kunming Medical University; Yunnan Province Young and Middle-aged Academic and Technical Leaders Reserve Talent Program; Yunnan Provincial Science and Technology Department; [82160007]; [2021JXD212]; [2021JXD227]; [2023535D12]; [202305AC160017]; [2019FE001(-58)]
第一作者机构:[1]Kunming Med Univ, Affiliated Hosp 1, Dept Pulm & Crit Care Med, Kunming, Peoples R China[2]Kunming Med Univ, Anesthesiol, Kunming, Peoples R China
共同第一作者:
通讯作者:
通讯机构:[1]Kunming Med Univ, Affiliated Hosp 1, Dept Pulm & Crit Care Med, Kunming, Peoples R China[3]295 Xichang Rd, Kunming, Peoples R China
推荐引用方式(GB/T 7714):
Yang Qianni,Li Min,Hou Yunjiao,et al.High-mobility group box 1 emerges as a therapeutic target for asthma[J].IMMUNITY INFLAMMATION AND DISEASE.2023,11(12):doi:10.1002/iid3.1124.
APA:
Yang, Qianni,Li, Min,Hou, Yunjiao,He, Huilin&Sun, Shibo.(2023).High-mobility group box 1 emerges as a therapeutic target for asthma.IMMUNITY INFLAMMATION AND DISEASE,11,(12)
MLA:
Yang, Qianni,et al."High-mobility group box 1 emerges as a therapeutic target for asthma".IMMUNITY INFLAMMATION AND DISEASE 11..12(2023)